Pear Therapeutics

Entity > Corporation > US > New York City New York > Pear Therapeutics

About Pear Therapeutics

Pear Therapeutics Inc. is a biotechnology and software company providing digital therapeutic platforms to treat disease and improve drug efficacy. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants.

Pear Therapeutics, Inc. Offers Prescription Digital Therapeutics (PDTs): Prescription digital therapeutics from Pear Therapeutics are software-based treatments for diseases in therapeutic areas such as psychiatric and neurological disorders. Pear Therapeutics was the first company in the world to receive Food and Drug Administration (FDA) approval for PDTs, which are claimed to improve clinical outcomes of diseases.

Pear Therapeutics, Inc. Has The First Three PDTs Approved By the FDA To Treat Diseases: Pear Therapeutics' first product, reSET, for the treatment of substance use disorders, was the first PDT to receive FDA approval for the treatment of disease. The second product, reSET-O, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. The third product, Somryst, for the treatment of chronic insomnia, was the first PDT submitted through the FDA's traditional 510(k) pathway and simultaneously reviewed under the FDA's Software Precertification Pilot Program.

Founding: Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts, and was founded in 2013 by Corey McCann, Stephen Smith, and William Greene.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Pear Therapeutics

Company Attribute Value
Address StreetAddress: 200 State St, AddressLocality: Boston, AddressRegion: Massachusetts, PostalCode: 2109, AddressCountry: United States
Founding Date 2013
Name Pear Therapeutics
Number Of Employees 300
Revenue $6,581,000 USD
Ticker Symbol NASDAQ: PEAR
Url peartherapeutics
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google
Wikidata wikidata

Pear Therapeutics


New York City, US
7 Apr 2024

New York City, US
7 Apr 2024

Pear Therapeutics

Page: 1 Desktop | Laptop Devices › medtech › pear-pulped...
Pear Therapeutics apps sell for $6M in post-bankruptcy ...
May 19, 2023 — Click Therapeutics—itself a developer of apps to help treat migraine, smoking cessation, depression and more—offered $70,000 for the patents ... › Innovation › Healthcare
Pear Therapeutics Files For Bankruptcy As CEO Blames ...
Apr 7, 2023 — P ear Therapeutics, which has three FDA-cleared prescription apps to help treat substance use disorder and insomnia, filed for bankruptcy on ...
Pear Therapeutics
Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates ... › view
What Does Pear Therapeutics' Bankruptcy Mean for PDTs?
Jun 9, 2023 — Pear Therapeutics Inc. was a pioneer in digital therapeutics — and prescription digital therapeutics in particular — so when the Boston ... › news › pear-therape...
Pear Therapeutics assets sold for $6M at auction after ...
May 19, 2023 — The assets of prescription digital therapeutics maker Pear Therapeutics have been broken up and sold at auction for $6.05 million after the ... › members › pear-therapeutics
Pear Therapeutics
Pear Therapeutics is the leader in FDA-cleared prescription digital therapeutics. The company's approach is to integrate clinically-validated software ... › organization › pear-ther...
Pear Therapeutics - Crunchbase Company Profile & Funding
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. › pear-the...
Pear Therapeutics: a lesson for future DTx developers
Oct 24, 2023 — Pear Therapeutics was a pioneer in developing DTx for neurological conditions that are traditionally treated by evidence-based behavioural ... › 2024/01/18 › digital-therap...
How digital therapeutics firms are pivoting after ... - STAT News
Jan 18, 2024 — The bankruptcy of Pear Therapeutics last year proved that selling software-based treatments like drugs is harder than anticipated. Pear ... › data › peartherapeuticsfilesforch
Press Release, dated April 7, 2023
Apr 7, 2023 — Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process. BOSTON – April 7, 2023 – Pear Therapeutics, Inc.
Related Searches
Related Searches
pear therapeutics website
pear therapeutics app
pear therapeutics products
Knowledge Panel
Knowledge Panel

Pear Therapeutics (Commercial company)

  • Headquarters : Boston, MA
  • Founded : 2013

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 134196